Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-omics-Based Approach

被引:539
作者
Del Chierico, Federica [1 ]
Nobili, Valerio [1 ]
Vernocchi, Pamela [1 ]
Russo, Alessandra [1 ]
De Stefanis, Cristiano [1 ]
Gnani, Daniela [1 ]
Furlanello, Cesare [1 ]
Alessandro, Zandon A. [1 ]
Paci, Paola [1 ]
Capuani, Giorgio [1 ]
Dallapiccola, Bruno [1 ]
Miccheli, Alfredo [1 ]
Alisi, Anna [1 ]
Putignani, Lorenza [1 ]
机构
[1] Bambino Gesiu Childrens Hosp, Hepato Metabol Dis Unit, IRCCS PS Onofrio 4, I-00165 Rome, Italy
关键词
PATHOGENESIS; STEATOHEPATITIS; METABOLISM; MANAGEMENT; REGRESSION; CIRRHOSIS; ALCOHOL; AXIS;
D O I
10.1002/hep.28572
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There is evidence that nonalcoholic fatty liver disease (NAFLD) is affected by gut microbiota. Therefore, we investigated its modifications in pediatric NAFLD patients using targeted metagenomics and metabolomics. Stools were collected from 61 consecutive patients diagnosed with nonalcoholic fatty liver (NAFL), nonalcoholic steatohepatitis (NASH), or obesity and 54 healthy controls (CTRLs), matched in a case-control fashion. Operational taxonomic units were pyrosequenced targeting 16S ribosomal RNA and volatile organic compounds determined by solid-phase microextraction gas chromatography-mass spectrometry. The alpha-diversity was highest in CTRLs, followed by obese, NASH, and NAFL patients; and beta-diversity distinguished between patients and CTRLs but not NAFL and NASH. Compared to CTRLs, in NAFLD patients Actinobacteria were significantly increased and Bacteroidetes reduced. There were no significant differences among the NAFL, NASH, and obese groups. Overall NAFLD patients had increased levels of Bradyrhizobium, Anaerococcus, Peptoniphilus, Propionibacterium acnes, Dorea, and Ruminococcus and reduced proportions of Oscillospira and Rikenellaceae compared to CTRLs. After reducing metagenomics and metabolomics data dimensionality, multivariate analyses indicated a decrease of Oscillospira in NAFL and NASH groups and increases of Ruminococcus, Blautia, and Dorea in NASH patients compared to CTRLs. Of the 292 volatile organic compounds, 26 were up-regulated and 2 down-regulated in NAFLD patients. Multivariate analyses found that combination of Oscillospira, Rickenellaceae, Parabacteroides, Bacteroides fragilis, Sutterella, Lachnospiraceae, 4methyl-2-pentanone, 1-butanol, and 2-butanone could discriminate NAFLD patients from CTRLs. Univariate analyses found significantly lower levels of Oscillospira and higher levels of 1-pentanol and 2-butanone in NAFL patients compared to CTRLs. In NASH, lower levels of Oscillospira were associated with higher abundance of Dorea and Ruminococcus and higher levels of 2-butanone and 4-methyl-2-pentanone compared to CTRLs. Conclusion: An Oscillospira decrease coupled to a 2-butanone up-regulation and increases in Ruminococcus and Dorea were identified as gut microbiota signatures of NAFL onset and NAFL-NASH progression, respectively.
引用
收藏
页码:451 / 464
页数:14
相关论文
共 42 条
  • [1] The role of the gut microbiota in nonalcoholic fatty liver disease
    Abu-Shanab, Ahmed
    Quigley, Eamonn M. M.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2010, 7 (12) : 691 - 701
  • [2] Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
    Alisi, Anna
    Ceccarelli, Sara
    Panera, Nadia
    Nobili, Valerio
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2 : 1 - 4
  • [3] Gut microbiota and non-alcoholic fatty liver disease: new insights
    Aron-Wisnewsky, J.
    Gaborit, B.
    Dutour, A.
    Clement, K.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 338 - 348
  • [4] Bajaj J S., 2012, The American Journal of Gastroenterology Supplements, V1, P9
  • [5] Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
    Bajaj, Jasmohan S.
    Hylemon, Phillip B.
    Ridlon, Jason M.
    Heuman, Douglas M.
    Daita, Kalyani
    White, Melanie B.
    Monteith, Pamela
    Noble, Nicole A.
    Sikaroodi, Masoumeh
    Gillevet, Patrick M.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2012, 303 (06): : G675 - G685
  • [6] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [7] Hypothesis-generating research and predictive medicine
    Biesecker, Leslie G.
    [J]. GENOME RESEARCH, 2013, 23 (07) : 1051 - 1053
  • [8] Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease
    Boursier, Jerome
    Diehl, Anna Mae
    [J]. PLOS PATHOGENS, 2015, 11 (01) : 1 - 6
  • [9] Metagenome and metabolism: the tissue microbiota hypothesis
    Burcelin, Remy
    Serino, Matteo
    Chabo, Chantal
    Garidou, Lucile
    Pomie, Celine
    Courtney, Michael
    Amar, Jacques
    Bouloumie, Anne
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 : 61 - 70
  • [10] Regulation of Metabolism: A Cross Talk Between Gut Microbiota and Its Human Host
    Burcelin, Remy
    [J]. PHYSIOLOGY, 2012, 27 (05) : 300 - 307